Center for Basic and Translational Stroke Research
The mission of this Center is to understand and develop treatments for brain inflammation and cell death that result from stroke or other neural injury, such as traumatic brain injury. The CBTSR has strong programs in the cellular basis for brain inflammation, signaling pathways that mediate cell death, and blood/brain barrier structure and function. A key focus of this group is on rehabilitation following neural injury based on fundamental understanding of motor control circuitry and exploration of the brain/machine interface.
Dr. Ali Rezai, executive chair of the West Virginia University Rockefeller Neuroscience Institute, lays out his bold, new vision for neuroscience at WVU. Joining Dr. Rezai are WVU President Gorden Gee, Albert Wright, president and chief executive officer of the West Virginia University Health System, and Clay Marsh, MD, vice president and executive dean for Health Science at WVU.
Research drives patient care at any large academic medical center. As stroke treatment has dramatically evolved in the past decade, WVU Medicine’s neurointerventionists have emerged as national leaders in their relatively new field. Here, Ansaar Rai, MD, WVU Medicine Radiology vice chair of clinical operations, discusses the past and present of stroke treatment.
Neurosurgeons treat their patients through the use of a delicate, targeted procedure; the best neurosurgeons are skilled at several. WVU Medicine neurosurgeon Robert A. Marsh, MD, PhD, says his best approach is unique to each patient, and considers wishes as well as needs.